Screener
Disc Medicine IRON Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205192
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $11,759 | $9,018 |
| Accrued external research and development expenses | 12,137 | 11,451 |
| Other accrued expenses | 6,827 | 15,561 |
| Operating lease liabilities, current | 419 | 611 |
| Total current liabilities | 31,142 | 36,641 |
| Long-term debt, net | 29,365 | 29,159 |
| Operating lease liabilities, non-current | 1,277 | 1,253 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Disc Medicine's accrued expenses?
- Disc Medicine (IRON) reported accrued expenses of $6.83M in Q1 2026.
- How has Disc Medicine's accrued expenses changed year-over-year?
- Disc Medicine's accrued expenses increased by 65.0% year-over-year, from $4.14M to $6.83M.
- What is the long-term trend for Disc Medicine's accrued expenses?
- Over 5 years (2020 to 2025), Disc Medicine's accrued expenses has grown at a 99.5% compound annual growth rate (CAGR), from $492.59K to $15.56M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Disc Medicine's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude